EGFR amplification and lack of activating mutations in metaplastic breast carcinomas-Reference-Cited by-同舟云学术

EGFR amplification and lack of activating mutations in metaplastic breast carcinomas

Published:2006 Issue:4 Volume:209 Page:445-453
ISSN:0022-3417
Container-title:The Journal of Pathology
language:en
Short-container-title:J. Pathol.

Author:

Reis-Filho JS,Pinheiro C,Lambros MBK,Milanezi F,Carvalho S,Savage K,Simpson PT,Jones C,Swift S,Mackay A,Reis RM,Hornick JL,Pereira EM,Baltazar F,Fletcher CDM,Ashworth A,Lakhani SR,Schmitt FC

Publisher

Wiley

Subject

Pathology and Forensic Medicine

Reference57 articles.

1. ERBB receptors and cancer: the complexity of targeted inhibitors

2. Critical Update and Emerging Trends in Epidermal Growth Factor Receptor Targeting in Cancer

3. Prognostic Value of 1p, 19q, 9p, 10q, and EGFR-FISH Analyses in Recurrent Oligodendrogliomas

4. Evaluation of Epidermal Growth Factor Receptor (EGFR) by Chromogenic In Situ

5. Epidermal Growth Factor Receptor Inhibitors in the Treatment of Non–Small-Cell Lung Cancer

Cited by 229 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Translational Aspects in Metaplastic Breast Carcinoma;Cancers;2024-04-07

2. Integrative multi-omics characterization reveals sex differences in glioblastoma;Biology of Sex Differences;2024-03-16

3. Compartmental Syndecan-1 (CD138) expression as a novel prognostic marker in triple-negative metaplastic breast cancer;Pathology - Research and Practice;2024-01

4. Busting the Breast Cancer with AstraZeneca’s Gefitinib;Advances in Pharmacological and Pharmaceutical Sciences;2023-12-04

5. Molecular Classification of Breast Cancer;PET Clinics;2023-10